John Mark O'Mahony - May 26, 2021 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Chief Manufacturing Officer
Signature
/s/ Douglas E. Onsi, as attorney-in-fact for John Mark O'Mahony
Stock symbol
LPTX
Transactions as of
May 26, 2021
Transactions value $
$0
Form type
4
Date filed
5/28/2021, 08:35 PM
Next filing
Feb 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Employee Stock Option (Right to Buy) Award $0 +30K $0.00 30K May 26, 2021 Common Stock 30K $1.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of May 26, 2021, the Vesting Start Date.